Compliance Certificate in accordance with Regulation 74(5) of SEBI (DP) Regulations, 2018 For quarter ended 31 March 2026

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close

+6.5%1-day move

₹56.29

prior close

—

base price

After-mkt

timing

5m10m15m30m1D2D3D4D5D7D15D1M2M3M

————+6.5+5.4-0.5-0.5-0.5+20.8+6.6+61.6+108.9+67.8

Up moveDown movePending

AI summary

Aspira Pathlab & Diagnostics has filed its quarterly compliance certificate for Q4 FY2026 (ending March 31, 2026) with BSE. The certificate, issued by MUFG Intime India Private Limited (the company's Registrar & Share Transfer Agent), confirms that securities received for dematerialization during the quarter were properly processed and accepted or rejected within prescribed timelines. The filing also confirms that physical security certificates were mutilated and cancelled after verification, and depository names were substituted as registered owners in the register of members. This is a routine regulatory filing required under SEBI regulations for all listed companies.

Likely market impact

This is a standard, non-material compliance filing confirming proper handling of dematerialization requests. It has no direct impact on the company's financials or stock price and is filed routinely as part of SEBI's regulatory requirements for listed companies.